CERT

Certara Inc. (CERT) | Rumor.io

Certara

CERT

Attention (50-day avg)0%

Attention rank (50-day avg)#3,093

Bullish sentiment (50-day avg)100%

Price to earnings ratio105

Market capitalization1.4B

Earnings per share-0.14

Dividend yield (TTM)—

Revenue (annual)418.8M

Net income (annual)-1.6M

Social

What share of all stock conversation is about CERT?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% +0	0% 0	0% 0

Nov 26

Certara's stock price has outperformed the market when insiders buy the dip, according to a recent analysis of 120,554 insider trades.
The analysis found that stocks tend to increase in value after insiders purchase shares, suggesting a positive correlation between insider buying and stock performance.
Certara's stock price has historically responded positively to insider buying, making it a potentially attractive investment opportunity.

Generated by AI

Sentiment

Of the messages about CERT that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	100% 0	71.35% -16.7
Bearish	—	—	0% 0	28.65% +16.7

Topics

Of the messages about CERT that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	100%	69.72%
Technical Analysis	—	—	0%	7.04%
Analysts	—	—	0%	13.38%
Controversies	—	—	0%	0.7%
Earnings	—	—	0%	6.34%
Macro	—	—	0%	2.82%

Nov 7

Certara, Inc. ($CERT) has announced a new $449M investment from Arsenal Capital Partners, a private equity firm specializing in healthcare companies.
The investment will result in Arsenal acquiring approximately 30M shares at $15 per share from funds controlled by EQT Private Equity, with a two-year lock-up on the sale of shares.
Certara shares have risen 21% following the announcement, with the company also reporting its Third Quarter 2022 Financial Results, which included revenue guidance and reaffirmed FY22 EPS guidance.

Generated by AI

Community

Of the messages about CERT, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	0%	14.88%
Newcomers	100%	100%	100%	85.12%

Regulars· Mar 2

Certara, Inc. ($CERT) has released its Q4 earnings results, which missed expectations by $0.01 EPS.
The company beat Q4 revenue estimates with $86.6M vs. $82.55M.
Certara has entered a bullish trend, with its EPS and revenue beating expectations.

Newcomers· Nov 7

New investors are excited about Certara, Inc.'s (CERT) 18% stock price increase due to a $449M investment from Arsenal Capital Partners.
The new investment has triggered a lock-up agreement, where Arsenal will acquire approximately 30M shares at $15 per share, and agree to a two-year lock-up on sale of shares.
Certara's Q3 earnings report showed a miss on EPS ($0.10 vs $0.12 estimate) and a beat on sales ($84.70M vs $81.48M estimate), with the stock price up 12.77% at $12.01.

Generated by AI

On August 4, Certara (NASDAQ:CERT) reported second-quarter 2026 results that told two different stories at once. Software revenue climbed 4% to $48.8 million, and bookings for that segment jumped 9%, yet the company swung to a $6.1 million net loss just a year after posting a small profit. Layered on top of a completed divestiture, […]

16d agoYahoo Finance

Certara Corrects EBITDA Disclosure in Earnings Presentation

Detailed price information for Certara Inc (CERT-Q) from The Globe and Mail including charting and trades.

1mo agotheglobeandmail.com

The Bull Case For Certara (CERT) Could Change Following Wider Q2 Loss And Leadership Shake-Up - Learn Why

1mo agoYahoo Finance

BMO Capital Sticks to Its Hold Rating for Certara (CERT)

Detailed price information for Certara Inc (CERT-Q) from The Globe and Mail including charting and trades.

1mo agoThe Globe and Mail

Certara Announces Leadership Change in Commercial Executive Role

Detailed price information for Certara Inc (CERT-Q) from The Globe and Mail including charting and trades.

1mo agotheglobeandmail.com

Certara Earnings Call: Software Strength Amid Services Strain

Detailed price information for Certara Inc (CERT-Q) from The Globe and Mail including charting and trades.

1mo agoThe Globe and Mail

Also Discussed

Investors talking about CERT also mention

#	Name	Attention
1	Schrödinger, Inc.SDGR	0%-0.01
2	AbCellera Biologics Inc.ABCL	0.24%-0.06
3	ICU Medical, Inc.ICUI	0%0
4	CONMED CorporationCNMD	0%new
5	PubMatic Inc. Class A Common StockPUBM	0%0
6	EXAI - Exscientia plc	——
7	Evolent Health IncEVH	0%0
8	Rhythm Pharmaceuticals, Inc.RYTM	0%0
9	Integra LifeSciences Holdings CorporationIART	0%0
10	IDEAYA Biosciences Inc.IDYA	0%-0.01

Certara Inc.

Healthcare
Health Information Services

Certara Inc. is a life sciences software and services company focused on biosimulation and model-informed drug development. Certara provides software tools and technology-enabled services that help pharmaceutical, biotechnology, and regulatory organizations model drug behavior, analyze pharmacokinetics and pharmacodynamics, and support clinical development and regulatory submissions. Its offerings include biosimulation platforms, clinical data automation and validation software, regulatory authoring and submission tools, and market access solutions. The company serves organizations across drug discovery, preclinical research, clinical research, and post-approval activities, supporting more data-driven decision-making throughout the drug development lifecycle. Certara Inc. plays a specialized role in the healthcare market by helping customers improve development efficiency, strengthen evidence generation, and navigate complex regulatory requirements.

Website

Location

4 Radnor Corporate Center

Radnor, PA, 19087

United States

Social

What share of all stock conversation is about CERT?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% +0	0% 0	0% 0

Nov 26

Certara's stock price has outperformed the market when insiders buy the dip, according to a recent analysis of 120,554 insider trades.
The analysis found that stocks tend to increase in value after insiders purchase shares, suggesting a positive correlation between insider buying and stock performance.
Certara's stock price has historically responded positively to insider buying, making it a potentially attractive investment opportunity.

Generated by AI

Sentiment

Of the messages about CERT that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	100% 0	71.35% -16.7
Bearish	—	—	0% 0	28.65% +16.7

Topics

Of the messages about CERT that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	100%	69.72%
Technical Analysis	—	—	0%	7.04%
Analysts	—	—	0%	13.38%
Controversies	—	—	0%	0.7%
Earnings	—	—	0%	6.34%
Macro	—	—	0%	2.82%

Nov 7

Certara, Inc. ($CERT) has announced a new $449M investment from Arsenal Capital Partners, a private equity firm specializing in healthcare companies.
The investment will result in Arsenal acquiring approximately 30M shares at $15 per share from funds controlled by EQT Private Equity, with a two-year lock-up on the sale of shares.
Certara shares have risen 21% following the announcement, with the company also reporting its Third Quarter 2022 Financial Results, which included revenue guidance and reaffirmed FY22 EPS guidance.

Generated by AI

Community

Of the messages about CERT, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	0%	14.88%
Newcomers	100%	100%	100%	85.12%

Regulars· Mar 2

Certara, Inc. ($CERT) has released its Q4 earnings results, which missed expectations by $0.01 EPS.
The company beat Q4 revenue estimates with $86.6M vs. $82.55M.
Certara has entered a bullish trend, with its EPS and revenue beating expectations.

Newcomers· Nov 7

New investors are excited about Certara, Inc.'s (CERT) 18% stock price increase due to a $449M investment from Arsenal Capital Partners.
The new investment has triggered a lock-up agreement, where Arsenal will acquire approximately 30M shares at $15 per share, and agree to a two-year lock-up on sale of shares.
Certara's Q3 earnings report showed a miss on EPS ($0.10 vs $0.12 estimate) and a beat on sales ($84.70M vs $81.48M estimate), with the stock price up 12.77% at $12.01.

Generated by AI

Certara

Social

Nov 26

Sentiment

Topics

Nov 7

Community

Regulars· Mar 2

Newcomers· Nov 7

News

Certara (CERT) Slashes Jobs While Doubling Down On Software Growth

Certara Corrects EBITDA Disclosure in Earnings Presentation

The Bull Case For Certara (CERT) Could Change Following Wider Q2 Loss And Leadership Shake-Up - Learn Why

BMO Capital Sticks to Its Hold Rating for Certara (CERT)

Certara Announces Leadership Change in Commercial Executive Role

Certara Earnings Call: Software Strength Amid Services Strain

Also Discussed

Certara Inc.

Company Information

Location

Social

Nov 26

Sentiment

Topics

Nov 7

Community

Regulars· Mar 2

Newcomers· Nov 7

News

Certara (CERT) Slashes Jobs While Doubling Down On Software Growth

Certara Corrects EBITDA Disclosure in Earnings Presentation

The Bull Case For Certara (CERT) Could Change Following Wider Q2 Loss And Leadership Shake-Up - Learn Why

BMO Capital Sticks to Its Hold Rating for Certara (CERT)

Certara Announces Leadership Change in Commercial Executive Role

Certara Earnings Call: Software Strength Amid Services Strain

Also Discussed